Balang, Rosita A.

HRN: 23-52-85  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/15/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/15/2023
08/21/2023
IV
500mg
Q8h
Ameobiasis
Waiting Final Action 
08/16/2023
CIPROFLOXACIN 500MG (TAB)
08/16/2023
08/22/2023
PO
500MG
BID
UTI
Waiting Final Action 
08/18/2023
METRONIDAZOLE 500MG (TAB)
08/18/2023
08/20/2023
PO
500mg
TID
Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: